Baldwin Investment Management’s Novo Nordisk NVO Stock Holding History

Baldwin Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Sell	20,958 -591	-3%	-$25.4K	0.1%	118
2026 Q1	$792K	Hold	21,549	–	–	0.09%	121
2025 Q4	$1.1M	Sell	21,549 -325	-1%	-$16.6K	0.12%	98
2025 Q3	$1.21M	Hold	21,874	–	–	0.14%	94
2025 Q2	$1.51M	Sell	21,874 -441	-2%	-$30K	0.18%	70
2025 Q1	$1.55M	Buy	22,315 +575	+3%	+$47.5K	0.19%	67
2024 Q4	$1.87M	Sell	21,740 -440	-2%	-$47.6K	0.24%	56
2024 Q3	$2.64M	Hold	22,180	–	–	0.33%	45
2024 Q2	$3.17M	Sell	22,180 -461	-2%	-$61.1K	0.43%	35
2024 Q1	$2.91M	Sell	22,641 -1,295	-5%	-$154K	0.39%	38
2023 Q4	$2.48M	Buy	23,936 +200	+0.8%	+$19.8K	0.39%	40
2023 Q3	$2.16M	Hold	23,736	–	–	0.36%	44
2023 Q2	$1.92M	Sell	23,736 -622	-3%	-$50.8K	0.32%	54
2023 Q1	$1.94M	Hold	24,358	–	–	0.34%	52
2022 Q4	$1.65M	Sell	24,358 -748	-3%	-$43.9K	0.3%	59
2022 Q3	$1.25K	Sell	25,106 -786	-3%	-$42.1K	0.25%	68
2022 Q2	$1.44K	Hold	25,892	–	–	0.27%	66
2022 Q1	$1.44K	Hold	25,892	–	–	0.22%	77
2021 Q4	$1.45K	Sell	25,892 -1,000	-4%	-$54.2K	0.23%	82
2021 Q3	$1.29M	Hold	26,892	–	–	0.22%	77
2021 Q2	$1.13M	Buy	26,892 +716	+3%	+$27.8K	0.19%	91
2021 Q1	$882K	Sell	26,176 -960	-4%	-$34.2K	0.16%	108
2020 Q4	$948K	Sell	27,136 -200	-0.7%	-$6.91K	0.19%	95
2020 Q3	$949K	Hold	27,336	–	–	0.22%	79
2020 Q2	$895K	Buy	27,336 +372	+1%	+$11.9K	0.28%	59
2020 Q1	$812K	Sell	26,964 -1,910	-7%	-$56.9K	0.28%	56
2019 Q4	$836K	Hold	28,874	–	–	0.22%	68
2019 Q3	$746K	Buy	28,874 +602	+2%	+$15.2K	0.22%	69
2019 Q2	$722K	Buy	28,272 +1,000	+4%	+$24.7K	0.21%	76
2019 Q1	$713K	Hold	27,272	–	–	0.21%	75
2018 Q4	$628K	Buy	27,272 +1,000	+4%	+$22.2K	0.2%	77
2018 Q3	$619K	Hold	26,272	–	–	0.18%	87
2018 Q2	$606K	Buy	26,272 +10,200	+63%	+$242K	0.19%	88
2018 Q1	$396K	Sell	16,072 -88	-0.5%	-$2.31K	0.14%	80
2017 Q4	$434K	Hold	16,160	–	–	0.15%	78
2017 Q3	$389K	Buy	16,160 +152	+0.9%	+$3.44K	0.15%	83
2017 Q2	$343K	Buy	16,008 +222	+1%	+$4.48K	0.14%	84
2017 Q1	$271K	Hold	15,786	–	–	0.11%	106
2016 Q4	$283K	Sell	15,786 -50	-0.3%	-$906	0.11%	104
2016 Q3	$329K	Hold	15,836	–	–	0.14%	98
2016 Q2	$426K	Sell	15,836 -700	-4%	-$19.2K	0.18%	83
2016 Q1	$448K	Sell	16,536 -26	-0.2%	-$697	0.19%	81
2015 Q4	$481K	Hold	16,562	–	–	0.22%	74
2015 Q3	$449K	Hold	16,562	–	–	0.2%	78
2015 Q2	$453K	Sell	16,562 -112	-0.7%	-$3.15K	0.19%	80
2015 Q1	$445K	Hold	16,674	–	–	0.18%	84
2014 Q4	$353K	Hold	16,674	–	–	0.14%	99
2014 Q3	$397K	Hold	16,674	–	–	0.16%	90
2014 Q2	$385K	Sell	16,674 -46	-0.3%	-$1.02K	0.17%	92
2014 Q1	$382K	Sell	16,720 -750	-4%	-$16K	0.17%	91
2013 Q4	$323K	Hold	17,470	–	–	0.15%	102
2013 Q3	$296K	Buy	17,470 +420	+2%	+$7.06K	0.14%	104
2013 Q2	$264K	Buy	+17,050	New	+$284K	0.13%	103

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Baldwin Investment Management's NVO Position: Q2 2026 in Review

Baldwin Investment Management reduced its Novo Nordisk (NVO) stake by 2.7% in Q2 2026, selling an estimated $25.4K and leaving 20,958 shares worth $1M. The position accounts for 0.1% of the portfolio, ranked #118.

Baldwin Investment Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.17M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Baldwin Investment Management held 20,958 shares of Novo Nordisk worth $1M as of Q2 2026.
Baldwin Investment Management sold 591 Novo Nordisk shares in Q2 2026, an estimated $25.4K.
Novo Nordisk made up 0.1% of Baldwin Investment Management's portfolio in Q2 2026, its #118 holding.
Baldwin Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
Baldwin Investment Management's Novo Nordisk position peaked at $3.17M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.